Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial (Q33434238)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial (English)

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

interstitial lung disease

1 reference

based on heuristic

inferred from title

Jonathan Goldin

object named as

Jonathan Goldin

7

0 references

Marvin J Fritzler

41

object named as

Marvin J Fritzler

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Charlie Strange

13

object named as

Charlie Strange

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Donald P Tashkin

1

object named as

Donald P Tashkin

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

2

object named as

Michael D Roth

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

author name string

Philip J Clements

3

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Daniel E Furst

4

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Dinesh Khanna

5

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Eric C Kleerup

6

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Edgar Arriola

8

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Elizabeth R Volkmann

9

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Suzanne Kafaja

10

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Richard Silver

11

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Virginia Steen

12

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Robert Wise

14

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Fredrick Wigley

15

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Maureen Mayes

16

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

David J Riley

17

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Sabiha Hussain

18

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Shervin Assassi

19

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Vivien M Hsu

20

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Bela Patel

21

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Kristine Phillips

22

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Fernando Martinez

23

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Jeffrey Golden

24

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

M Kari Connolly

25

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

John Varga

26

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Jane Dematte

27

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Monique E Hinchcliff

28

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Aryeh Fischer

29

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Jeffrey Swigris

30

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Richard Meehan

31

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Arthur Theodore

32

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Robert Simms

33

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Suncica Volkov

34

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Dean E Schraufnagel

35

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Mary Beth Scholand

36

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Tracy Frech

37

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Jerry A Molitor

38

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Kristin Highland

39

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Charles A Read

40

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Grace Hyun J Kim

42

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Chi-Hong Tseng

43

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Robert M Elashoff

44

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Sclerodema Lung Study II Investigators

45

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

publication date

25 July 2016

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

The Lancet. Respiratory medicine

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

4

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

9

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

708-719

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

A joint model for longitudinal measurements and survival data in the presence of multiple failure types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

21 June 2018

Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

31 October 2018

Joint analysis of bivariate longitudinal ordinal outcomes and competing risks survival times with nonparametric distributions for random effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

31 October 2018

Adverse events during the Scleroderma Lung Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

31 October 2018

The effects and mechanisms of mycophenolate mofetil on pulmonary arterial hypertension in rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

31 October 2018

Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

31 October 2018

Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

31 October 2018

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014629

31 October 2018

Prediction of pulmonary complications and long-term survival in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930152-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930152-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide for scleroderma lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930152-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930152-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930152-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930152-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930152-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930152-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27469583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S2213-2600(16)30152-7

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33434238&oldid=2102383643"